Jonas Brambeck
Director
life sciences
Oncopeptides AB (ONCO.ST)
Sweden
Biography
Jonas Brambeck has been Director of Oncopeptides AB since 2008. In addition to being a board member of Oncopeptides, Jonas is an Investment Manager at Industrifonden, a leading Nordic venture capital fund, and a member of the Board of Directors of the life sciences companies Oxthera AB, Cardoz AB and Nuevolution AS. He is also Board Member of Athera Biotechnologies AB, CMC Contrast AB and OxThera Intellectual Property AB. He has previously held positions at a number of life sciences businesses including AstraZeneca, Bruker Instruments and Nobel. Jonas holds a Ph.D. in organic chemistry from The Royal Institute of Technology in Stockholm.
Research Interest
organic chemistry life sciences
